Founded in 1929, Reig Jofre is #5 Spanish pharmaceutical company by turnover that trades on the Spanish stock exchange under the ticker RJF. It is devoted to the research, development, manufacture and marketing of pharmaceutical products and nutritional supplements, as well as on specialized contract development and manufacturing. The company directs its activity in two business units: • technological specialization area (49.7% of total sales) in the development and manufacture of antibiotics derived from penicillin and sterile injectable products, which made possible to grow internationally and distribute or license Reig Jofre products in more than 65 countries on five continents. • therapeutic areas and health care (50.3% of sales) focused on the research, development, manufacture and marketing of our own developments in dermatology and gynecology, mainly, and in the development of OTCs products in the field of ENT and topical disinfectants. This area also includes the line of nutritional supplements, marketed under Forté Pharma brand, mainly in France, Belgium, Spain and Portugal. Reig Jofre has about 1,000 employees, 4 development and manufacturing centers in Europe (Spain: 1 in Barcelona &, 2 in Toledo; and 1 in Sweden), direct sales in 7 countries and over 130 commercial partners in more than 65 countries worldwide.  

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

Our Resources

Categories affiliated with Reig Jofre